GeneDx Holdings WGS Cash Flow Statement (2020-2026)

NASDAQ WGS
$89.17 -1.12 (-1.23%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

GeneDx Holdings Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

GeneDx Holdings reported cash from operations of -$28.98M and free cash flow of -$39.09M for the quarter ended Jun 2026, down 378.1% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
32.73M-40.19M-76.90M-85.74M-77.58M-308.71M-60.99M-46.72M-42.29M-25.77M-20.22M-29.16M-8.31M5.44M-6.53M10.81M-7.63M-17.67M-63.32M-17.74M
Share-based CompensationStock Comp.
18.01M36.97M17.56M154.44M0.05M6.64M-6.05M-0.45M3.11M3.64M2.85M3.98M7.81M10.59M9.78M12.09M3.25M
Deferred Taxes
-49.08M-0.10M0.05M-0.15M-0.20M-0.17M-0.41M-0.08M-0.19M-0.05M-0.02M0.45M-0.24M0.25M0.90M-0.52M
Gains from Investment SecuritiesGains Investment
81.70M-76.23M-13.19M-28.18M-12.98M-15.88M3.45M-3.55M-0.59M-0.49M6.10M4.41M0.88M1.98M1.10M-2.18M3.40M-1.12M-2.54M-0.22M
Asset Writedowns and ImpairmentWritedown
-1.34M1.01M0.04M174.50M2.12M8.28M0.04M0.04M0.15M-0.02M31.29M
Cash from OperationsCash from Ops.
-70.94M-51.98M-81.49M-84.64M-88.36M-64.65M-55.56M-53.50M-41.23M-29.86M-16.41M-4.50M-4.39M-3.18M10.18M10.42M15.77M-3.09M-32.41M-28.98M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.07M0.13M0.13M0.13M0.13M0.13M0.13M0.13M
Depreciation & Amortization (CF)Dep. & Amort.
5.50M5.79M5.80M
Change in Working Capital
Change in ReceivablesChange Receivables
-3.31M5.25M11.13M-13.49M-3.13M-0.04M-9.72M-0.45M-0.55M0.20M-4.22M-2.40M12.47M-0.67M8.56M1.33M12.91M13.43M2.56M6.68M
Change in InventoryChange Inventory
0.70M3.29M2.90M-0.62M2.96M-7.59M-1.33M1.82M-1.17M-0.29M2.88M-1.22M0.48M0.45M2.03M-0.63M-1.33M3.36M-1.69M5.66M
Change in Accured ExpensesChange Accured Exp.
-5.10M20.99M-6.58M42.30M-7.16M5.90M-13.40M-12.00M-14.51M-9.25M-4.73M-6.14M3.06M-12.72M10.82M-3.62M-2.01M6.92M-13.17M0.60M
Other Working Capital ChangesOther WC Changes
-0.85M-0.02M-0.41M-0.07M9.09M-0.16M2.79M-3.32M1.90M-0.80M4.29M1.03M-4.13M-4.74M-3.12M12.01M-10.72M-10.14M9.12M10.90M
Investing Activities
Capital ExpendituresCapex
2.59M2.64M2.54M1.92M2.04M0.67M1.07M1.69M0.11M2.38M0.44M1.35M0.82M2.88M6.13M2.37M6.17M4.35M6.45M10.11M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.25M0.15M
Acquisitions
-0.34M
Change in Acquisitions & DivestmentsChange Acquisitions
16.66M1.10M5.86M2.87M16.23M16.11M13.93M12.78M7.25M10.02M8.50M11.97M
Cash from Investing ActivitiesCash from Investing
-3.62M-7.69M-3.91M-130.30M-4.28M-2.84M-0.46M-11.27M-27.13M-4.86M0.84M-22.70M-7.75M-0.52M-9.41M-36.35M-4.69M-11.07M-17.25M-5.63M
Financing Activities
Other financing activitiesOther financing
0.02M0.28M0.70M197.01M-0.05M135.44M7.56M0.02M0.14M14.43M31.91M13.89M-0.13M11.80M21.14M97.00M-95.20M
Cash from Financing ActivitiesCash from Financing
499.40M-1.03M-0.16M198.06M-0.65M0.07M132.66M7.39M-0.91M47.10M-0.44M-0.39M13.97M31.02M13.72M0.35M10.77M23.19M38.59M1.00M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
350.00M-197.71M197.66M7.60M0.48M
Additional items
Change in Cash
424.85M-60.71M-85.57M-16.89M-93.29M-67.43M76.64M-57.38M-69.27M12.38M-16.01M-27.60M1.82M27.32M14.49M-25.58M21.85M9.03M-11.07M-33.61M
Free Cash FlowFCF
-73.53M-54.62M-84.03M-86.57M-90.40M-65.33M-56.63M-55.19M-41.34M-32.23M-16.86M-5.86M-5.21M-6.06M4.05M8.05M9.60M-7.44M-38.86M-39.09M
Net Cash FlowNCF
424.85M-60.71M-85.57M-16.89M-93.29M-67.43M76.64M-57.38M-69.27M12.38M-16.01M-27.60M1.82M27.32M14.49M-25.58M21.85M9.03M-11.07M-33.61M